Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |